• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白癜风中 Janus 激酶 1(JAK1)表达的免疫组织化学研究

Immunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo.

作者信息

Abdou Asmaa Gaber, Maraee Alaa, Yassien Hossam, Sarhan Mona

机构信息

Department of Pathology, Faculty of Medicine, Menoufia University, Shebein Elkom, Egypt.

Department of Dermatology, Faculty of Medicine, Menoufia University, Shebein Elkom, Egypt.

出版信息

J Pathol Transl Med. 2018 Nov;52(6):363-368. doi: 10.4132/jptm.2018.09.18. Epub 2018 Oct 23.

DOI:10.4132/jptm.2018.09.18
PMID:30347972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6250933/
Abstract

BACKGROUND

Vitiligo is a chronic autoimmune disease in which the destruction of melanocytes causes white spots on the affected skin. Janus kinase (JAK) is a family of intracellular, non-receptor tyrosine kinases that transduce cytokine-mediated signals via the JAK-signal transducer and activator of transcription pathway. The aim of the present study is to explore the possible role of JAK1 in the pathogenesis of vitiligo using immunohistochemical methods.

METHODS

The current study was conducted in a sample of 39 patients who presented with vitiligo and 22 healthy individuals who were age and sex matched as a control group. We used immunohistochemistry to evaluate JAK1 status (intensity and distribution) and assess the percentage of residual melanocytes using human melanoma black 45 (HMB45).

RESULTS

Intense and diffuse JAK1 expression was significantly more likely to indicate vitiliginous skin compared to normal skin (p < .001). Strong and diffuse JAK1 expression was associated with short disease duration, female sex, and lower percentage of melanocytes (detected by HMB45) (p < .05).

CONCLUSIONS

JAK1 may be involved in the pathogenesis of vitiligo, as indicated by intense and diffuse expression compared to control and association with lower percentage of melanocytes detected by HMB45 immunostaining.

摘要

背景

白癜风是一种慢性自身免疫性疾病,其中黑素细胞的破坏导致受影响皮肤出现白斑。Janus激酶(JAK)是一类细胞内非受体酪氨酸激酶家族,其通过JAK-信号转导子和转录激活子途径转导细胞因子介导的信号。本研究的目的是使用免疫组织化学方法探讨JAK1在白癜风发病机制中的可能作用。

方法

本研究纳入了39例白癜风患者作为样本,并选取22例年龄和性别匹配的健康个体作为对照组。我们使用免疫组织化学评估JAK1状态(强度和分布),并使用人黑素瘤黑色45(HMB45)评估残余黑素细胞的百分比。

结果

与正常皮肤相比,强烈且弥漫的JAK1表达更有可能提示白癜风皮肤(p <.001)。强烈且弥漫的JAK1表达与病程短、女性以及较低的黑素细胞百分比(通过HMB45检测)相关(p <.05)。

结论

与对照组相比,JAK1的强烈且弥漫表达以及与HMB45免疫染色检测到的较低黑素细胞百分比相关,提示JAK1可能参与白癜风的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37de/6250933/a545cf7b5d34/jptm-2018-09-18f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37de/6250933/a545cf7b5d34/jptm-2018-09-18f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37de/6250933/a545cf7b5d34/jptm-2018-09-18f1.jpg

相似文献

1
Immunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo.白癜风中 Janus 激酶 1(JAK1)表达的免疫组织化学研究
J Pathol Transl Med. 2018 Nov;52(6):363-368. doi: 10.4132/jptm.2018.09.18. Epub 2018 Oct 23.
2
Cutaneous JAK Expression in Vitiligo.白癜风的皮肤 JAK 表达。
J Cutan Med Surg. 2021 Mar-Apr;25(2):157-162. doi: 10.1177/1203475420972340. Epub 2020 Nov 11.
3
Role of Janus kinase 1 and signal transducer and activator of transcription 3 in vitiligo.Janus激酶1和信号转导及转录激活因子3在白癜风中的作用。
Clin Cosmet Investig Dermatol. 2019 Jun 28;12:469-480. doi: 10.2147/CCID.S210106. eCollection 2019.
4
Expression of Janus Kinase 1 in vitiligo & psoriasis before and after narrow band UVB: a case-control study.Janus 激酶 1 在窄谱 UVB 治疗前后白癜风和银屑病中的表达:一项病例对照研究。
Arch Dermatol Res. 2018 Jan;310(1):39-46. doi: 10.1007/s00403-017-1792-6. Epub 2017 Nov 10.
5
Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: an implication for pathogenesis.免疫组化分析白癜风中 Notch-1 信号通路的异常表达:对发病机制的启示。
Ann Diagn Pathol. 2014 Jun;18(3):117-24. doi: 10.1016/j.anndiagpath.2014.01.002. Epub 2014 Jan 13.
6
Activation of Janus kinase signaling pathway in acne lesions.痤疮皮损中 Janus 激酶信号通路的激活。
Dermatol Ther. 2021 Jan;34(1):e14563. doi: 10.1111/dth.14563. Epub 2020 Nov 30.
7
Immunohistochemical study of janus kinase 1/signal transducer and activator of transcription 3 in psoriasis vulgaris.寻常型银屑病中Janus激酶1/信号转导及转录激活因子3的免疫组织化学研究
Clin Cosmet Investig Dermatol. 2019 Jul 2;12:497-508. doi: 10.2147/CCID.S202835. eCollection 2019.
8
Differential role of Janus family kinases (JAKs) in interferon-gamma-induced lung epithelial ICAM-1 expression: involving protein interactions between JAKs, phospholipase Cgamma, c-Src, and STAT1.Janus家族激酶(JAKs)在干扰素-γ诱导的肺上皮细胞细胞间黏附分子-1(ICAM-1)表达中的差异作用:涉及JAKs、磷脂酶Cγ、c-Src和信号转导及转录激活因子1(STAT1)之间的蛋白质相互作用
Mol Pharmacol. 2004 Mar;65(3):589-98. doi: 10.1124/mol.65.3.589.
9
Janus kinase JAK1 maintains the ovarian reserve of primordial follicles in the mouse ovary.Janus 激酶 JAK1 维持小鼠卵巢原始卵泡的卵巢储备。
Mol Hum Reprod. 2018 Nov 1;24(11):533-542. doi: 10.1093/molehr/gay041.
10
Immunohistochemical Analysis of GDNF and Its Cognate Receptor GFRα-1 Protein Expression in Vitiliginous Skin Lesions.白癜风皮损中胶质细胞源性神经营养因子(GDNF)及其同源受体GFRα-1蛋白表达的免疫组织化学分析
J Cutan Med Surg. 2016 Mar-Apr;20(2):130-4. doi: 10.1177/1203475415601828. Epub 2015 Sep 2.

引用本文的文献

1
The immunological pathogenesis of vitiligo and the potential role of mesenchymal stromal/stem cells in its treatment.白癜风的免疫发病机制及间充质基质/干细胞在其治疗中的潜在作用。
J Transl Med. 2025 Jul 1;23(1):707. doi: 10.1186/s12967-025-06627-8.
2
Treatment Advances in Vitiligo: An Updated Review.白癜风的治疗进展:最新综述
Dermatol Pract Concept. 2025 Jan 30;15(1):4600. doi: 10.5826/dpc.1501a4600.
3
Repigmentation in non-segmental vitiligo using the Janus kinase inhibitor upadacitinib, a retrospective case series.使用JAK激酶抑制剂乌帕替尼治疗非节段型白癜风的色素再生:一项回顾性病例系列研究

本文引用的文献

1
Expression of Janus Kinase 1 in vitiligo & psoriasis before and after narrow band UVB: a case-control study.Janus 激酶 1 在窄谱 UVB 治疗前后白癜风和银屑病中的表达:一项病例对照研究。
Arch Dermatol Res. 2018 Jan;310(1):39-46. doi: 10.1007/s00403-017-1792-6. Epub 2017 Nov 10.
2
Steroidogenic genes expressions are repressed by high levels of leptin and the JAK/STAT signaling pathway in MA-10 Leydig cells.甾体生成基因的表达受高浓度瘦素和 MA-10 间质细胞中 JAK/STAT 信号通路的抑制。
Mol Cell Biochem. 2017 Sep;433(1-2):79-95. doi: 10.1007/s11010-017-3017-x. Epub 2017 Mar 25.
3
Investigation of factors associated with health-related quality of life and psychological distress in vitiligo.
Arch Dermatol Res. 2024 Dec 20;317(1):143. doi: 10.1007/s00403-024-03658-x.
4
Upadacitinib and its role in the treatment of vitiligo: A new possible therapeutic perspective.乌帕替尼及其在白癜风治疗中的作用:一种新的潜在治疗前景。
JAAD Case Rep. 2024 Feb 21;46:57-58. doi: 10.1016/j.jdcr.2024.01.033. eCollection 2024 Apr.
5
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art.白癜风:从发病机制到治疗进展的最新研究进展。
Int J Mol Sci. 2023 Mar 3;24(5):4910. doi: 10.3390/ijms24054910.
6
Signaling pathways in rheumatoid arthritis: implications for targeted therapy.类风湿关节炎中的信号通路:靶向治疗的意义。
Signal Transduct Target Ther. 2023 Feb 17;8(1):68. doi: 10.1038/s41392-023-01331-9.
7
Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream.开发用于靶向局部递送的JAK抑制剂:芦可替尼乳膏。
Pharmaceutics. 2021 Jul 8;13(7):1044. doi: 10.3390/pharmaceutics13071044.
8
Targeting the Janus Kinase Family in Autoimmune Skin Diseases.靶向自身免疫性皮肤病中的 Janus 激酶家族。
Front Immunol. 2019 Oct 9;10:2342. doi: 10.3389/fimmu.2019.02342. eCollection 2019.
白癜风患者健康相关生活质量及心理困扰相关因素的调查
J Dtsch Dermatol Ges. 2016 Jan;14(1):45-9. doi: 10.1111/ddg.12729.
4
Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy.枸橼酸托法替布治疗白癜风:一种针对发病机制的治疗方法。
JAMA Dermatol. 2015 Oct;151(10):1110-2. doi: 10.1001/jamadermatol.2015.1520.
5
Role of protein tyrosine kinase inhibitors in cancer therapeutics.蛋白酪氨酸激酶抑制剂在癌症治疗中的作用。
Indian J Biochem Biophys. 2004 Dec;41(6):273-80.
6
Over-expression of tumor necrosis factor-α in vitiligo lesions after narrow-band UVB therapy: an immunohistochemical study.窄谱中波紫外线治疗后白癜风皮损中肿瘤坏死因子-α的过度表达:免疫组化研究。
Arch Dermatol Res. 2012 Dec;304(10):823-30. doi: 10.1007/s00403-012-1269-6. Epub 2012 Jul 26.
7
Pyridone 6, a pan-JAK inhibitor, ameliorates allergic skin inflammation of NC/Nga mice via suppression of Th2 and enhancement of Th17.吡啶酮 6,一种泛 JAK 抑制剂,通过抑制 Th2 和增强 Th17 来改善 NC/Nga 小鼠的过敏性皮肤炎症。
J Immunol. 2011 Nov 1;187(9):4611-20. doi: 10.4049/jimmunol.1100649. Epub 2011 Sep 28.
8
Role of interleukin-17 in the pathogenesis of vitiligo.白细胞介素-17 在白癜风发病机制中的作用。
Clin Exp Dermatol. 2011 Apr;36(3):292-7. doi: 10.1111/j.1365-2230.2010.03972.x. Epub 2010 Dec 24.
9
Reduced skin homing by functional Treg in vitiligo.白癜风中功能性 Treg 减少皮肤归巢。
Pigment Cell Melanoma Res. 2010 Apr;23(2):276-86. doi: 10.1111/j.1755-148X.2010.00688.x. Epub 2010 Feb 19.
10
Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.白癜风患者病灶周围的T细胞对皮肤黑素细胞进行自身免疫破坏。
J Invest Dermatol. 2009 Sep;129(9):2220-32. doi: 10.1038/jid.2009.32. Epub 2009 Feb 26.